T. Awan

Therapeutic Approaches to Prion Diseases : In Vitro Studies with Tetracycline Compounds

G. Forloni, F. Tagliavini, M. Salmona, 2002 .

Studying the morphological features of plasma treated silver and PEGylated silver nanoparticles: antibacterial activity

H. M. Yasin, T. Awan, N. Rehman, 2018 .

Tetracyclines affect prion infectivity

G. Forloni, F. Tagliavini, M. Salmona, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease

H. Budka, J. Laplanche, H. Bernheimer, 2000, Neurology.

NEUROPATHOLOGICAL CORRELATES OF MAGNETIC RESONANCE ABNORMALITIES IN EXPERIMENTAL PRION DISEASE

F. Tagliavini, O. Bugiani, B. Canciani, 1999 .

Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro.

G. Forloni, F. Tagliavini, L. De Gioia, 2000, Journal of molecular biology.

Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126.

G. Forloni, F. Tagliavini, L. De Gioia, 1999, The Biochemical journal.

Polymorphism at codon 129 of PRNP affects the phenotypic expression of Creutzfeldt‐Jakob disease linked to E200K mutation

F. Tagliavini, P. Lievens, O. Bugiani, 2000, Annals of neurology.